DK333388A - Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller - Google Patents

Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller

Info

Publication number: DK333388A
Authority: DK; Denmark
Prior art keywords: pharmaceutical preparations; preparations containing; containing micronized; crystals; ebselen
Prior art date: 1987-06-20

Application number

DK333388A

Other languages

English (en)

Other versions

DK173628B1 (da

DK333388D0 (da

Inventor

Axel Roemer

Juergen Seidel

Original Assignee

Nattermann A & Cie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-20

Filing date

1988-06-17

Publication date

1988-12-21

1988-06-17 Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie

1988-06-17 Publication of DK333388D0 publication Critical patent/DK333388D0/da

1988-12-21 Publication of DK333388A publication Critical patent/DK333388A/da

2001-05-07 Application granted granted Critical

2001-05-07 Publication of DK173628B1 publication Critical patent/DK173628B1/da

Links

DYEFUKCXAQOFHX-UHFFFAOYSA-N Ebselen Chemical compound [se]1C2=CC=CC=C2C(=O)N1C1=CC=CC=C1 DYEFUKCXAQOFHX-UHFFFAOYSA-N 0.000 title abstract 5
229950010033 ebselen Drugs 0.000 title abstract 4
239000013078 crystal Substances 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D293/12—Selenazoles; Hydrogenated selenazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

DK198803333A 1987-06-20 1988-06-17 Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller DK173628B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3720493		1987-06-20
DE19873720493 DE3720493A1 (de)	1987-06-20	1987-06-20	Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (3)

Publication Number	Publication Date
DK333388D0 DK333388D0 (da)	1988-06-17
DK333388A true DK333388A (da)	1988-12-21
DK173628B1 DK173628B1 (da)	2001-05-07

Family

ID=6330016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198803333A DK173628B1 (da)	1987-06-20	1988-06-17	Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller

Country Status (25)

Country	Link
US (1)	US5021242A (da)
EP (1)	EP0296389B1 (da)
JP (1)	JPH0713016B2 (da)
KR (1)	KR970005322B1 (da)
AT (1)	ATE69165T1 (da)
AU (1)	AU603454B2 (da)
CA (1)	CA1310906C (da)
DD (1)	DD271056A5 (da)
DE (2)	DE3720493A1 (da)
DK (1)	DK173628B1 (da)
ES (1)	ES2041736T3 (da)
FI (1)	FI88256C (da)
GE (1)	GEP19960342B (da)
GR (1)	GR3003084T3 (da)
HU (1)	HU200096B (da)
IE (1)	IE63512B1 (da)
LT (1)	LT3669B (da)
LV (1)	LV10381B (da)
MX (1)	MX169170B (da)
NO (1)	NO175133C (da)
NZ (1)	NZ225066A (da)
PT (1)	PT87767B (da)
RU (1)	RU1834657C (da)
UA (1)	UA12648A (da)
ZA (1)	ZA884025B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5368864A (en) *	1988-11-25	1994-11-29	Henning Berlin Gmbh Chemie- Und Pharmawerk	Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) *	1991-12-03	1994-03-11	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) *	1992-04-28	1996-11-13	第一製薬株式会社	粒状製剤
ES2145065T3 (es) *	1993-10-27	2000-07-01	Daiichi Seiyaku Co	Preparacion granular.
US5609883A (en) *	1994-09-16	1997-03-11	Advanced Technology Pharmaceuticals Corporation	Compressed tablet transitory lubricant system
US5618845A (en)	1994-10-06	1997-04-08	Cephalon, Inc.	Acetamide derivative having defined particle size
EP0812195B1 (en) *	1995-02-28	2002-10-30	Aventis Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol compounds
NZ501248A (en) *	1997-08-26	2001-06-29	Aventis Pharma Inc	Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) *	1999-01-08	2001-06-05	Maxim Pharmaceuticals, Inc.	Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US7671211B1 (en)	1999-03-31	2010-03-02	Arne Holmgren	Substrates for thioredoxin reductase
AU4239302A (en) *	2001-06-28	2003-01-02	Pfizer Products Inc.	Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) *	2002-07-12	2004-03-11	Craig Heacock	Modafinil pharmaceutical compositions
CA2511992A1 (en) *	2003-02-24	2004-09-10	Mallinckrodt Inc.	Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) *	2003-04-29	2004-12-16	Barr Laboratories, Inc.	Surface-treated modafinil particles
US20080181966A1 (en) *	2006-10-18	2008-07-31	Cephalon, Inc.	Modafinil pharmaceutical compositions
WO2008148064A1 (en) *	2007-05-23	2008-12-04	Sunesis Pharmaceuticals, Inc.	Weight loss treatment
GB201102248D0 (en)	2011-02-09	2011-03-23	Isis Innovation	Treatment of bipolar disorder
US10058542B1 (en)	2014-09-12	2018-08-28	Thioredoxin Systems Ab	Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en)	2014-09-26	2016-04-16	Helsinn Healthcare Sa	Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) *	2021-02-02	2022-08-11	Haiku Therapeutics Ltd	Ebselen as adenosine receptor modulator
EP4536191A1 (en) *	2022-06-06	2025-04-16	Sound Pharmaceuticals Incorporated	Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3027073C2 (de) *	1980-07-17	1985-03-07	A. Nattermann & Cie GmbH, 5000 Köln	Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) *	1984-03-01	1985-09-05	A. Nattermann & Cie GmbH, 5000 Köln	Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) *	1986-05-20	1987-11-26	Nattermann A & Cie	Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) *	1986-06-20	1987-12-23	Nattermann A & Cie	Salbe zur behandlung von hauterkrankungen

1987
- 1987-06-20 DE DE19873720493 patent/DE3720493A1/de not_active Withdrawn
1988
- 1988-05-30 IE IE162888A patent/IE63512B1/en not_active IP Right Cessation
- 1988-06-01 ES ES88108767T patent/ES2041736T3/es not_active Expired - Lifetime
- 1988-06-01 AT AT88108767T patent/ATE69165T1/de not_active IP Right Cessation
- 1988-06-01 DE DE8888108767T patent/DE3866033D1/de not_active Expired - Lifetime
- 1988-06-01 EP EP88108767A patent/EP0296389B1/de not_active Expired - Lifetime
- 1988-06-06 ZA ZA884025A patent/ZA884025B/xx unknown
- 1988-06-14 CA CA000569410A patent/CA1310906C/en not_active Expired - Lifetime
- 1988-06-14 NO NO882615A patent/NO175133C/no not_active IP Right Cessation
- 1988-06-15 KR KR1019880007178A patent/KR970005322B1/ko not_active Expired - Lifetime
- 1988-06-16 MX MX011927A patent/MX169170B/es unknown
- 1988-06-17 FI FI882912A patent/FI88256C/fi active IP Right Grant
- 1988-06-17 HU HU883120A patent/HU200096B/hu unknown
- 1988-06-17 UA UA4355988A patent/UA12648A/uk unknown
- 1988-06-17 AU AU18116/88A patent/AU603454B2/en not_active Expired
- 1988-06-17 JP JP63148414A patent/JPH0713016B2/ja not_active Expired - Lifetime
- 1988-06-17 NZ NZ225066A patent/NZ225066A/xx unknown
- 1988-06-17 PT PT87767A patent/PT87767B/pt not_active IP Right Cessation
- 1988-06-17 DK DK198803333A patent/DK173628B1/da not_active IP Right Cessation
- 1988-06-17 DD DD88316885A patent/DD271056A5/de unknown
- 1988-06-17 RU SU884355988A patent/RU1834657C/ru active
- 1988-06-20 US US07/209,325 patent/US5021242A/en not_active Expired - Lifetime
1991
- 1991-11-07 GR GR91401696T patent/GR3003084T3/el unknown
1993
- 1993-01-15 LV LVP-93-32A patent/LV10381B/lv unknown
- 1993-08-17 GE GEAP19931457A patent/GEP19960342B/en unknown
- 1993-08-30 LT LTIP903A patent/LT3669B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ225066A (en)	1990-07-26
ES2041736T3 (es)	1996-07-16
LT3669B (en)	1996-01-25
EP0296389A1 (de)	1988-12-28
EP0296389B1 (de)	1991-11-06
AU1811688A (en)	1988-12-22
UA12648A (uk)	1997-02-28
DK173628B1 (da)	2001-05-07
HUT50037A (en)	1989-12-28
LV10381A (lv)	1995-02-20
NO175133B (no)	1994-05-30
FI88256B (fi)	1993-01-15
ZA884025B (en)	1988-12-20
DE3720493A1 (de)	1989-01-26
HU200096B (en)	1990-04-28
KR970005322B1 (ko)	1997-04-15
MX169170B (es)	1993-06-23
IE63512B1 (en)	1995-05-03
US5021242A (en)	1991-06-04
LV10381B (en)	1995-06-20
DD271056A5 (de)	1989-08-23
NO882615L (no)	1988-12-21
NO175133C (no)	1994-09-07
PT87767B (pt)	1992-10-30
JPH01100125A (ja)	1989-04-18
AU603454B2 (en)	1990-11-15
GEP19960342B (en)	1996-02-20
JPH0713016B2 (ja)	1995-02-15
DK333388D0 (da)	1988-06-17
RU1834657C (ru)	1993-08-15
GR3003084T3 (en)	1993-02-17
CA1310906C (en)	1992-12-01
IE881628L (en)	1988-12-20
NO882615D0 (no)	1988-06-14
FI882912L (fi)	1988-12-21
FI882912A0 (fi)	1988-06-17
PT87767A (pt)	1989-05-31
ATE69165T1 (de)	1991-11-15
LTIP903A (en)	1995-03-27
KR890000084A (ko)	1989-03-11
DE3866033D1 (de)	1991-12-12
FI88256C (fi)	1993-04-26

Legal Events

Date	Code	Title	Description
2001-05-07	B1	Patent granted (law 1993)
2008-07-07	PUP	Patent expired

Publication	Publication Date	Title
DK333388D0 (da)	1988-06-17	Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller
IS3156A7 (is)	1987-04-30	Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
SE8700499D0 (sv)	1987-02-10	Novel pharmacologically active compounds
FI863652A0 (fi)	1986-09-10	7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
DK653688A (da)	1989-05-25	Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
ATE90345T1 (de)	1993-06-15	Bis-naphthalimide, ihre herstellung und verwendung.
ES2032376T3 (es)	1993-02-16	Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
DK0598770T3 (da)	1997-12-15	Pyrazinderivater samt fremstilling og anvendelse deraf
DK324185D0 (da)	1985-07-17	2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DE3583916D1 (de)	1991-10-02	Waessrige arzneiformulierungen des piroxicammonohydrats.
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
ES2012339B3 (es)	1990-03-16	Preparacion oral de ajo y procedimiento para su fabricacion
ATE21248T1 (de)	1986-08-15	Derivate von 1h,3h-pyrrolo(1,2-c)thiazol, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU539847B2 (en)	1984-10-18	3,4,5-trihydroxypiperidine compounds
GB2021409A (en)	1979-12-05	Pharmaceutical composition
ATE7698T1 (de)	1984-06-15	Vincamin-saccharinat und dieses enthaltende arzneimittel.
DK313587A (da)	1987-12-22	Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ATE12241T1 (de)	1985-04-15	Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
NO164651C (no)	1990-10-31	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminofenol-derivater.
SE8704049D0 (sv)	1987-10-16	Novel pharmacological compounds
ATE1339T1 (de)	1982-07-15	Heterocyclische carboxamidin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.